A randomised placebo-controlled trial of rivastigmine in delirium in older medical in-patients: a pilot study

Completed

• Conditions: Delirium; Signs and Symptoms; Delirium, not induced by alcohol and other psychoactive substances

• Registration Number: ISRCTN27327721
• Lead Sponsor: South Manchester University Hospitals NHS Trust (UK)

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Study Start: 2005-10-28
• Last Update Posted: 13 January 2015

Recruitment & Eligibility

• Status: Completed
• Sex: All
• Target Recruitment: 50

Inclusion Criteria

1. Patients over 65 years old
2. Admitted to elderly acute medical ward or orthopaedic ward
3. Patient has a delirium as measured on the Confusion Assessment Method or doesn't have a delirium and has a fractured neck of femur caused by trauma

Exclusion Criteria

1. Patient already on cholinesterase inhibitor
2. Patient has had a previous adverse reaction to a cholinesterase inhibitor
3. If considered by medical team in charge of care to be in the terminal phase of illness
4. Acute chronic obstructive pulmonary disease (COPD) or asthma
5. Has a dysrhythmia on electrocardiogram (ECG)
6. Urea >20 or creatinine >200

Study & Design

• Study Type: Interventional
• Study Design: Not specified